In certain embodiments, this disclosure relates to carbonic anhydrase inhibitors that are phenylureidobenzenesulfonamide derivatives and uses related thereto. In certain embodiments, the phenylureidobenzenesulfonamide derivatives are of Formula I, wherein the substituents are defined herein. In certain embodiments, the disclosure relates to pharmaceutical compositions comprising compounds disclosed herein and a pharmaceutically acceptable excipient.
在某些实施例中,本公开涉及苯基
脲基苯磺酰胺衍
生物的
碳酸酐酶
抑制剂及其相关用途。在某些实施例中,苯基
脲基苯磺酰胺衍
生物为式I的衍
生物,其中取代基在此定义。在某些实施例中,本公开涉及包含本公开披露的化合物和药用可接受的载体的药物组合物。